Humacyte, Inc. (NASDAQ:HUMA) Q4 2024 Earnings Call Transcript March 28, 2025
Humacyte, Inc. beats earnings expectations. Reported EPS is $-0.16, expectations were $-0.23.
Operator: Good morning, ladies and gentlemen. Welcome to the Humacyte Fourth Quarter Results Conference Call. Currently all participants are in listen-only mode. Later we’ll conduct a question-and-answer session and instructions will follow at that time. As a reminder, this conference call is being recorded. I’ll now turn...
